P-1422. Immunogenicity and Reactogenicity of Adjuvanted (Arexvy) and Non-Adjuvanted (Abrysvo) RSV Vaccines in Immunocompromised Individuals with Hematological Malignancies
P-1422. 佐剂（Arexvy）和非佐剂（Abrysvo）RSV疫苗在免疫功能低下且患有血液系统恶性肿瘤的个体中的免疫原性和反应原性
期刊:Evidence-Based Complementary and Alternative Medicine
影响因子:
doi:10.1155/2020/5651390
Olela, Ben; Mbaria, James; Wachira, Timothy; Moriasi, Gervason; Hannaford, Alisse; Izaguirre, Natalie E; Swank, Zoe; Van Haren, Simon D; Yates, Bridget; Kanwal, Urwah; Levine, Hannah; Tong, Alexandra; Shehata, Maria; Oladipupo, Fathia; Ryff, Kevin; Li, Xiaofang; Eustace, Aidan; Parisi, Lindsey; Hansen, Louise L; Sedney, Colleen J; Thomas, Sanya; Walt, David; Levy, Ofer; Kelkar, Amar H; Soiffer, Robert; Ho, Vincent; Lan, Zhou; Baden, Lindsey R; Issa, Nicolas C; Woolley, Ann E; Sherman, Amy C
